Delayed neurologic and behavioral effects of subtoxic doses of cholinesterase inhibitors

Journal of Pharmacology and Experimental Therapeutics

Volumn 304, Issue 3, 2003, Pages 1111-1119

  Scremin, Oscar U ^a   Shih, Tsung Ming ^a   Huynh, Ly ^a   Roch, Margareth ^a   Booth, Ruth ^a   Jenden, Donald J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE; CHOLINE ACETYLTRANSFERASE; CHOLINESTERASE; CHOLINESTERASE INHIBITOR; MUSCARINIC RECEPTOR; PYRIDOSTIGMINE; SARIN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY MASS; COGNITION; CONTROLLED STUDY; DOSE RESPONSE; HABITUATION; HIPPOCAMPUS; MALE; MESENCEPHALON; NONHUMAN; OPEN FIELD BEHAVIOR; PAIN THRESHOLD; PASSIVE AVOIDANCE; PERSIAN GULF SYNDROME; PRIORITY JOURNAL; PUTAMEN; RAT; RECEPTOR DOWN REGULATION; STARTLE REFLEX;

ACOUSTIC STIMULATION; ANIMALS; AVOIDANCE LEARNING; BODY WEIGHT; BRAIN; CHOLINESTERASE INHIBITORS; CHOLINESTERASES; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MODELS, ANIMAL; MOTOR ACTIVITY; PAIN MEASUREMENT; RATS; RATS, SPRAGUE-DAWLEY; SARIN; STARTLE REACTION;

EID: 0037369853     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.102.044818     Document Type: Article

References (40)

1. Burchfield JL and Duffy FH (1982) Organophosphate neurotoxicity: chronic effects of sarin on the electroencephalogram of monkey and man. Neurobehav Toxicol Teratol 4:767-778.
2. Chambers HW (1992) Organophosphorus compounds: an overview, in Organophosphates: Chemistry, Fate and Effects (Chambers JE and Levi PE eds), pp 3-17, Academic Press, San Diego.
3. Chippendale TJ, Jawelkow GA, Russell RW, and Overstreet DH (1972) Tolerance to low acetylcholinesterase levels: modification of behavior without acute behavioral change. Psychopharmacologia 26:127-139.
4. Coordinating Subcommittee (1985) Possible long term health effects of short term exposure to chemical agents, vol III, final report, current health status of test subjects. Committee on Toxicology, Board on Toxicology and Environmental Health Hazards, Assembly of Life Sciences National Academy, National Academy Press, Washington, DC.
5. Crocker AD and Russell RW (1984) The up-and-down method for the determination of nociceptive threshold. Pharmacol Biochem Behav 21:133-136.
6. Dirnhuber P, French MC, Green DM, Leadbeater L, and Stratton JA (1979) The protection of primates against soman poisoning by pretreatment with pyridostigmine. J Pharm Pharmacol 31:295-299.
7. Dixon WJ (1965) The up-and-down method for small samples. J Am Stat Assoc 60:967-978.
8. Ecobichon DJ and Joy RM (1982) Pesticides and Neurological Diseases, CRC Press, Boca Raton, FL.
9. Ellman GL, Courtney KD, Andres V Jr, and Featherstone RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88-95.
10. Fonnum F (1975) A rapid radiochemical method for the determination of choline acetyltransferase. J Neurochem 24:407-409.
11. Freireich EJ, Gehan EA, Rall DP, Schmidt LH, and Skipper HE (1966) Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey and man. Cancer Chemother Reports 50:219-244.
12. Haley RW (2001) Gulf syndrome research has passed peer review. Nature (Lond) 410:739.
13. Harris LW and Stitcher D (1984) Protection against diisopropylfluorophosphate intoxication by pyridostigmine and physostigmine in combination with atropine and mecamylamine. Naunyn-Schmiedeberg's Arch Pharmacol 327:64-69.
14. Hoy JB, Cody BA, Karlix JL, Schmidt CJ, Tebbett IR, Toffollo S, Van Haaren F, and Wielbo D (1999) Pyridostigmine bromide alters locomotion and thigmotaxis of rats: gender effects. Pharmacol Biochem Behav 63:401-406.
15. Kassa J, Koupilova M, Herink J, and Vachek J (2001a) The long-term influence of low-level sarin exposure on behavioral and neurophysiological functions in rats, Acta Medica (Hradec Kralove) 44:21-27.
16. Kassa J, Koupilova M, and Vachek J (2001b) The influence of low-level sarin inhalation exposure on spatial memory in rats. Pharmacol Biochem Behav 70:175-179.
17. Keeler JR Hurst CG, and Dunn MA (1991) Pyridostigmine used as a nerve agent pretreatment under wartime conditions. J Am Med Assoc 266:693-695.
18. Kluwe WM, Chinn JC, Feder P, Olson C, and Joiner R (1987) Efficacy of pyridostigmine pretreatment against acute soman intoxication in a primate model, in Proceedings of the Sixth Medical Chemical Defense Bioscience Review, pp 227-234, AD B121516. USAMRICD, Aberdeen Proving Ground, MD.
19. Koplovitz I, Gresham VC, Dochterman LW, Kaminskis A, and Stewart JR (1992) Evaluation of the toxicity, pathology and treatment of cyclohexylmethylphosphonofluoridate (CMPF) poisoning in rhesus monkeys. Arch Toxicol 66:622-628.
20. Leadbeater L, Inns RH, and Rylands JM (1985) Treatment of poisoning by soman. Fundam Appl Toxicol 5:S225-S231.
21. Liu F, Song Y, and Liu D (1999) Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Therapy 6:1258-1266.
22. Liu WF (1992) Acute effects of oral low doses of pyridostigmine on simple visual discrimination and unconditioned consummatory acts in rats. Pharmacol Biochem Behav 41:251-254.
23. McCauley LA, Rischitelli G, Lambert WE, Lasarev M, Sticker DL, and Spencer PS (2001) Symptoms of Gulf War veterans possibly exposed to organophosphate chemical warfare agents at Khamisiyah, Iraq, Int J Occup Environ Health 7:79-89.
24. McGaugh JL (1972) The search for the memory trace. Ann NY Acad Sci 193:112-123.
25. Moore DH (1998) Health effects of exposure to low doses of nerve agent: a review of present knowledge, Drug Chem Toxicol 21:123-130.
26. Overstreet DH (1977) Pharmacological approaches to habituation of the acoustic startle response in rats. Physiol Psychol 5:230-238.
27. Panel on Anticholinesterase Chemicals (1982) Possible long term health effects of short term exposure to chemical agents, vol I, anticholinesterases and anticholinergics, Committee on Toxicology and Environmental Health Hazards, Assembly of Life Sciences, National Academy Press, Washington, DC.
28. Russell RW (1982) Cholinergic system in behaviour: the search for mechanisms of action. Annu Rev Pharmacol Toxicol 22:435-463.
29. Russell RW, Booth RA, Lauretz SD, Smith CA, and Jenden DJ (1986) Behavioural, neurochemical and physiological effects of repeated exposures to subsymptomatic levels of the anticholinesterase, soman. Neurobehav Toxicol Teratol 8:675-685.
30. Russell RW, Jenden DJ, Booth RA, Lauretz SD, Rice KM, and Roch M (1990) Global in-vivo replacement of choline by N-aminodeanol. Testing a hypothesis about progressive degenerative dementia; II. Physiological and behavioral effects. Pharmacol Biochem Behav 37:811-820.
31. Russell RW and Macri J (1979) Central cholinergic involvement in behavioral hyperreactivity. Pharmacol Biochem Behav 10:43-48.
32. Servatius RJ, Ottenweller JE, Beldowicz D, Guo W, Zhu G, and Natelson BH (1998) Persistently exaggerated startle responses in rats treated with pyridostigmine bromide. J Pharmacol Exp Ther 287:1020-1028.
33. Shih JH, Liu WF, Lee SF, Lee JD, Ma C, and Lin CH (1991) Acute effects of oral pyridostigmine bromide on conditioned operant performance in rats. Pharmacol Biochem Behav 38:549-553.
34. Shih T-M, Lenz DE, and Maxwell DM (1990) Effects of repeated injection of sublethal doses of soman on behavior and on brain acetylcholine and choline concentration in the rat. Psychopharmacology 101:489-496.
35. Shih T-M and Romano JA (1988) The effects of choline on soman-induced analgesia and toxicity. Neurotoxicol Teratol 10:287-294.
36. Sidell FR (1974) Soman and sarin: clinical manifestations and treatment of accidental poisoning by organophosphates. Clin Toxicol 7:1-17.
37. Silverman RW, Chang AS, and Russell RW (1988) A microcomputer-controlled system for measuring reactivity in small animals. Behav Res Methods 20:495-498.
38. Switzer RC, Campbell SK, Murphy MR, Kerenyi SZ, Miller SA, and Hartgraves SK (1990) Soman-induced convulsions and brain damage as a function of chronic and acute exposure in rats and diazepam therapy in rhesus monkeys, in Proceedings of the Workshop on Convulsions and Related Brain Damage Induced by Organophosphorus Agents, pp 33-70, AD A222912, USAMRICD, Aberdeen Proving Ground, MD.
39. Wolthuis OL and Vanwersch RAP (1984) Behavioral changes in the rat after low doses of cholinesterase inhibitors. Fundam Appl Toxicol 4:195-208.
40. Yamamura HI and Snyder SH (1974) Muscarinic cholinergic binding in rat brain. Proc Natl Acad Sci USA 71:1725-1729.